258 related articles for article (PubMed ID: 30504346)
21. Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome.
Durrani J; Maciejewski JP
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):97-104. PubMed ID: 31808900
[TBL] [Abstract][Full Text] [Related]
22. Special Education: Aplastic Anemia.
Teramura M; Mizoguchi H
Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
[TBL] [Abstract][Full Text] [Related]
23. Clinical and Molecular Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria.
Gurnari C; Pagliuca S; Prata PH; Galimard JE; Catto LFB; Larcher L; Sebert M; Allain V; Patel BJ; Durmaz A; Pinto AL; Inacio MCB; Hernandez L; Dhedin N; Caillat-Zucman S; Clappier E; Sicre de Fontbrune F; Voso MT; Visconte V; Peffault de Latour R; Soulier J; Calado RT; Socié G; Maciejewski JP
J Clin Oncol; 2023 Jan; 41(1):132-142. PubMed ID: 36054881
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of acquired somatic mutations in aplastic anaemia.
Marsh JC; Mufti GJ
Int J Hematol; 2016 Aug; 104(2):159-67. PubMed ID: 27084249
[TBL] [Abstract][Full Text] [Related]
25. Long-term follow-up of clonal evolutions in 802 aplastic anemia patients: a single-center experience.
Li Y; Li X; Ge M; Shi J; Qian L; Zheng Y; Wang J
Ann Hematol; 2011 May; 90(5):529-37. PubMed ID: 21207031
[TBL] [Abstract][Full Text] [Related]
26. SWI/SNF subunit expression heterogeneity in human aplastic anemia stem/progenitors.
Sinha S; Chatterjee SS; Biswas M; Nag A; Banerjee D; De R; Sengupta A
Exp Hematol; 2018 Jun; 62():39-44.e2. PubMed ID: 29596882
[TBL] [Abstract][Full Text] [Related]
27. HLA associations, somatic loss of HLA expression, and clinical outcomes in immune aplastic anemia.
Zaimoku Y; Patel BA; Adams SD; Shalhoub R; Groarke EM; Lee AAC; Kajigaya S; Feng X; Rios OJ; Eager H; Alemu L; Quinones Raffo D; Wu CO; Flegel WA; Young NS
Blood; 2021 Dec; 138(26):2799-2809. PubMed ID: 34724566
[TBL] [Abstract][Full Text] [Related]
28. Polyclonal hematopoiesis maintained in patients with bone marrow failure harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells.
Ishiyama K; Chuhjo T; Wang H; Yachie A; Omine M; Nakao S
Blood; 2003 Aug; 102(4):1211-6. PubMed ID: 12676778
[TBL] [Abstract][Full Text] [Related]
29. Molecular pathogenesis of acquired aplastic anemia.
Boddu PC; Kadia TM
Eur J Haematol; 2019 Feb; 102(2):103-110. PubMed ID: 30380171
[TBL] [Abstract][Full Text] [Related]
30. Clonal evolution of aplastic anaemia to myelodysplasia/acute myeloid leukaemia and paroxysmal nocturnal haemoglobinuria.
Tooze JA; Marsh JC; Gordon-Smith EC
Leuk Lymphoma; 1999 Apr; 33(3-4):231-41. PubMed ID: 10221503
[TBL] [Abstract][Full Text] [Related]
31. The small population of PIG-A mutant cells in myelodysplastic syndromes do not arise from multipotent hematopoietic stem cells.
Pu JJ; Hu R; Mukhina GL; Carraway HE; McDevitt MA; Brodsky RA
Haematologica; 2012 Aug; 97(8):1225-33. PubMed ID: 22315493
[TBL] [Abstract][Full Text] [Related]
32. Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria/aplastic anemia is not associated with a selective proliferative defect in the glycosylphosphatidylinositol-anchored protein-deficient clone.
Maciejewski JP; Sloand EM; Sato T; Anderson S; Young NS
Blood; 1997 Feb; 89(4):1173-81. PubMed ID: 9028939
[TBL] [Abstract][Full Text] [Related]
33. High frequency of several PIG-A mutations in patients with aplastic anemia and myelodysplastic syndrome.
Okamoto M; Shichishima T; Noji H; Ikeda K; Nakamura A; Akutsu K; Maruyama Y
Leukemia; 2006 Apr; 20(4):627-34. PubMed ID: 16467865
[TBL] [Abstract][Full Text] [Related]
34. Utility of plasma cell-free DNA for
Gutierrez-Rodrigues F; Beerman I; Groarke EM; Patel BA; Spitofsky N; Dillon LW; Raffo DQ; Hourigan CS; Kajigaya S; Ferrucci L; Young NS
Haematologica; 2022 Aug; 107(8):1815-1826. PubMed ID: 34587721
[TBL] [Abstract][Full Text] [Related]
35. Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome.
Maciejewski JP; Follmann D; Nakamura R; Saunthararajah Y; Rivera CE; Simonis T; Brown KE; Barrett JA; Young NS
Blood; 2001 Dec; 98(13):3513-9. PubMed ID: 11739151
[TBL] [Abstract][Full Text] [Related]
36. Clinical implications of somatic mutations in aplastic anemia and myelodysplastic syndrome in genomic age.
Maciejewski JP; Balasubramanian SK
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):66-72. PubMed ID: 29222238
[TBL] [Abstract][Full Text] [Related]
37. Aplastic anemia and clonal evolution: germ line and somatic genetics.
Shimamura A
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):74-82. PubMed ID: 27913465
[TBL] [Abstract][Full Text] [Related]
38. Aplastic anemia: Etiology, molecular pathogenesis, and emerging concepts.
Shallis RM; Ahmad R; Zeidan AM
Eur J Haematol; 2018 Dec; 101(6):711-720. PubMed ID: 30055055
[TBL] [Abstract][Full Text] [Related]
39. Progressive telomere shortening in aplastic anemia.
Ball SE; Gibson FM; Rizzo S; Tooze JA; Marsh JC; Gordon-Smith EC
Blood; 1998 May; 91(10):3582-92. PubMed ID: 9572992
[TBL] [Abstract][Full Text] [Related]
40. [Pathophysiology of hematological malignancies associated with ASXL1 mutations].
Fujino T
Rinsho Ketsueki; 2022; 63(6):561-572. PubMed ID: 35831189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
